Dysregulation of the DRS, either through mutation of CHCHD4 (MIA40) substrates or changes in CHCHD4 expression, underlies pathophysiology associated with mitochondrial disease and cancer, respectively. The gene discussed is CHCHD4; the disease is inborn mitochondrial metabolism disorder.